Publications by authors named "K J Mammen"
Objectives: Although factors associated with alcohol use have been researched at a population level, descriptions of the alcohol and other drug (AOD) treatment-seeking population in New South Wales (NSW), Australia, are limited. This study addresses this gap by analyzing sociodemographic and health characteristics in the NSW AOD treatment-seeking population.
Methods: Self-reported Australian Treatment Outcomes Profile data on substance use, health ratings, and sociodemographic factors were acquired from public AOD services (offering services from counseling to ambulatory/inpatient withdrawal management) in 6 administrative health districts from 2016 to 2019 (n = 14,287).
Background: Nephrolithiasis is a global health problem. The recurrence rate after the first stone clearance is approximately 50% at 5 years. Metabolic abnormalities are an important factor responsible for stone recurrence.
View Article and Find Full Text PDFArticle Synopsis
- Routine outcome monitoring (ROM) involves tracking clients' progress during treatment and providing feedback, which has improved outcomes in mental health, but its effectiveness in alcohol and other drug (AOD) treatment hasn't been systematically reviewed.
- This systematic review analyzed studies from Medline, PsycInfo, and Scopus to see if feedback from ROM data positively impacts substance use, treatment attendance, and overall wellbeing in AOD treatment.
- The review included ten studies, with mixed results: while some showed feedback improved treatment retention and other outcomes, only one indicated significant substance use reduction, suggesting the need for larger studies to better evaluate the impact of feedback.
Article Synopsis
- The study examines the demographics, substance use, and self-rated health of individuals seeking treatment in New South Wales for various drugs, focusing on alcohol, opioids, and stimulants.
- A total of 14,087 people were analyzed; most were male (66.5%), aged 20-39 years (50.4%), and predominantly Australian-born (86.7%), with alcohol being the most common principal drug of concern.
- The findings indicate a high prevalence of social disadvantage and poor health outcomes among these individuals, suggesting the need for tailored health services that address the specific characteristics of each drug use group.
Aims: The Austraian Treatment Outcomes Profile (ATOP) is a brief clinical outcomes tool used widely in the Australian alcohol and other drugs treatment sector to monitor clients' substance use, health, wellbeing and clinical risk factors. It has demonstrated reliability and validity, and has recommended clinical cut-offs for assessing single-occasion client-rated health scores. This study determined clinically meaningful change thresholds for ATOP substance use and health and wellbeing variables for use by clinicians in monitoring client progress, and for quality improvement and service evaluation.
View Article and Find Full Text PDF